Meet Onegevity

Through personalized precision wellness, we endeavor to empower any individual seeking better health. Meet the team of researchers, doctors, and experts dedicated to making that happen.

How we got here

Scientific founders Joel Dudley and Chris Mason, pioneers in AI-based diagnostics and well-known researchers in their fields, created Onegevity to solve problems that haven’t yet been solved by traditional medicine.

The first problem to solve – conditions in the gut. Our company’s dedication to uncovering the mysteries of the gut is as much a personal pursuit as it is an intellectual one.

Dr. Dudley has suffered from Crohn’s disease and his wife has struggled with IBS, while Dr. Mason has dedicated his career to improving the understanding of the microbiome. Their experience with gut related issues gives Onegevity an added sense of mission.

With Drs. Dudley and Mason’s leadership and the support from a team of dedicated scientists, Onegevity continues to break new ground scientifically. Learn more about the latest research.

Founders

Onegevity is the brainchild of doctors who want to change how people understand and manage their health. Founders Dr. Joel Dudley and Dr. Chris Mason combined their expertise in the fields of multi-scale omics, bioinformatics, and machine learning to create a complete health intelligence platform.

Joel Dudley

Co-Founder

Joel Dudley is currently an Associate Professor of Genetics and Genomic Sciences and founding Director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai. His work is focused at the nexus of -omics, digital health, artificial intelligence (AI), scientific wellness, and healthcare delivery. His work has been featured in the Wall Street Journal, Scientific American, MIT Technology Review, CNBC, and other popular media outlets. He was named in 2014 as one of the 100 most creative people in business by Fast Company.

Chris Mason

Co-Founder

Dr. Mason is currently an Associate Professor at Weill Cornell Medicine, with appointments at the Tri-Institutional Program in Computational Biology and Medicine between Cornell, Memorial Sloan-Kettering Cancer Center and Rockefeller University, the Sandra and Edward Meyer Cancer Center, and the Feil Family Brain and Mind Research Institute. Christopher Mason completed his dual B.S. in Genetics and Biochemistry from University of Wisconsin-Madison and his Ph.D. in Genetics from Yale University.

Our People

We are Onegevity – a team of researchers, doctors, and dedicated individuals united under a single vision: improving precision wellness through the Onegevity Health Intelligence platform.